THSD7A staining of membranous glomerulopathy in clinical practice reveals cases with dual autoantibody positivity

Modern Pathology

Volumn 29, Issue 4, 2016, Pages 421-426

  Larsen, Christopher P ^a   Cossey, L Nicholas ^a   Beck, Laurence H ^b  

^a Nephropath   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; PHOSPHOLIPASE A2 RECEPTOR; THROMBOSPONDIN; THROMBOSPONDIN TYPE I DOMAIN CONTAINING 7A; UNCLASSIFIED DRUG; AUTOANTIGEN; PLA2R1 PROTEIN, HUMAN; THROMBOSPONDIN TYPE I DOMAIN CONTAINING 7A PROTEIN, HUMAN;

ARTICLE; CLINICAL PRACTICE; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KIDNEY BIOPSY; MAJOR CLINICAL STUDY; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL; STAINING; ADULT; AGED; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; IMMUNOLOGY; MALE; MIDDLE AGED; PROCEDURES; VALIDATION STUDY; WESTERN BLOTTING;

ADULT; AGED; AUTOANTIBODIES; AUTOANTIGENS; BLOTTING, WESTERN; FEMALE; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; RECEPTORS, PHOSPHOLIPASE A2; STAINING AND LABELING; THROMBOSPONDINS;

EID: 84957596260     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2016.32     Document Type: Article

References (14)

1. Beck LH, Bonegio RG, Lambeau G et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009;361:11-21
2. Larsen CP, Messias NC, Silva FG et al. Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor (PLA2R1) staining in renal biopsies. Mod Pathol 2013;26: 709-715
3. Hoxha E, Harendza S, Zahner G et al. An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 2011;26:2526-2532
4. Ruggenenti P, Debiec H, Ruggiero B et al. Antiphospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy. J Am Soc Nephrol 2015;26:2545-2458
5. Hoxha E, Thiele I, Zahner G et al. Phospholipase A2 receptor autoantibiodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol 2014;25:1357-1366
6. Tomas NM, Beck LHJ, Meyer-Schwesinger C et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 2014;371:2277-2287
7. Iwakura T, Ohashi N, Kato A et al. Prevalence of enhanced granular expression of thrombospondin type-domain-containing 7A in the glomeruli of Japanese patients with idiopathic membranous nephropathy. PLoS One 2015;10:e0138841
8. Walker PD, Cavallo T, Bonsib SM. Practice guidelines for the renal biopsy. Mod Pathol 2004;17:1555-1563
9. Walker PD. The renal biopsy. Arch Pathol Lab Med 2009;133:181-188
10. Larsen CP, Beggs ML, Walker PD et al. Histopathologic effect of APOL1 risk alleles in PLA2R-associated membranous glomerulopathy. Am J Kidney Dis 2014;64:156-163
11. Debiec H, Ronco P. PLA2R autoantibodies and PLA2R glomerular deposits in membranous nephropathy. N Engl J Med 2011;364:689-690
12. Stanescu HC, Arcos-Burgos M, Medlar A et al. Risk HLA-DQA1 and PLA2R1 alleles in idiopathic membranous nephropathy. N Engl J Med 2011;364: 616-626
13. Saeed M, Beggs ML, Walker PD et al. PLA2R-associated membranous glomerulopathy is modulated by common variants in PLA2R1 and HLA-DQA1 genes. Genes Immun 2014;15:556-561
14. Fresquet M, Jowitt TA, Gummadova J et al. Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy. J Am Soc Nephrol 2015;26:302-313